CS-28 THE TRANSCRIPTION FACTOR POU3f2 UNIFORMLY EXPRESS IN HUMAN GLIOMAS AND PROMOTES TUMORIGENESIS AND OVERALL GROWTH RATE IN VIVO

Por Rahman, Mohummad Aminur, Leiss, Lina, Lellahi, Mohammad S., Gjerde, Christiane H., Saed, Halala S., Mutlu, Ercan, Enger, Per Øyvind
Publicado em 2014

DS-04 DOPAMINE ADDICTION IN GLIOBLASTOMA MULTIFORME DURING CHEMOTHERAPY IS MEDIATED BY A DRD2/β-ARRESTIN/AKT SIGNALING COMPLEX

Por Prestegarden, Lars, Johannessen, Tor-Christian, Grudic, Amra, Sundstrøm, Terje, Saed, Halala, Varughese, Jobin, Lund-Johansen, Morten, Bjerkvig, Rolf
Publicado em 2014

AI-10 DISTINCT EGFR SIGNALING IN GLIOBLASTOMA: WILD-TYPE EGFR PROMOTES INVASION WHILE EGFRvIII DRIVES PROTOTYPICAL SFK c-SRC ACTIVATION TO FOSTER ANGIOGENESIS

Por Eskilsson, Eskil, Røsland, Gro, Talasila, Krishna, Jahedi, Rosa, Leiss, Lina, Saed, Halala, Keunen, Olivier, Foerster, Sarah, Euskirchen, Philipp, Hossain, Jubayer, Taxt, Torfinn, Jirik, Radovan, Lund-Johansen, Morten, Enger, Per Øyvind, Ritter, Christoph, Niclou, Simone, Bjerkvig, Rolf, Miletic, Hrvoje
Publicado em 2014

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation

Por Eskilsson, Eskil, Rosland, Gro V., Talasila, Krishna M., Knappskog, Stian, Keunen, Olivier, Sottoriva, Andrea, Foerster, Sarah, Solecki, Gergely, Taxt, Torfinn, Jirik, Radovan, Fritah, Sabrina, Harter, Patrick N., Välk, Kristjan, Al Hossain, Jubayer, Joseph, Justin V., Jahedi, Roza, Saed, Halala S., Piccirillo, Sara G., Spiteri, Inma, Leiss, Lina, Euskirchen, Philipp, Graziani, Grazia, Daubon, Thomas, Lund-Johansen, Morten, Enger, Per Øyvind, Winkler, Frank, Ritter, Christoph A., Niclou, Simone P., Watts, Colin, Bjerkvig, Rolf, Miletic, Hrvoje
Publicado no Neuro Oncol (2016)